SCHEMBL853558

SCHEMBL853558

CCOC(=O)C=C(c1ccccc1)c1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 3/20 0.55
ALDH1A1 P00352 1/20 0.49
HPGD P15428 1/20 0.49
MDH2 P40926 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
GABRA1 P14867 3/20 0.48
GABRA3 P34903 3/20 0.48
GABRG2 P18507 2/20 0.48
GABRB3 P28472 2/20 0.48
GABRA5 P31644 2/20 0.48
GABRA2 P47869 2/20 0.48
POLB P06746 1/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
LTA4H P09960 3/20 0.48
PLA2G2A P14555 3/20 0.48
HSP90AA1 P07900 1/20 0.48
HSP90AB1 P08238 1/20 0.48
HTR1D P28221 3/20 0.47
KIF20A O95235 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4030619 0.83 TRPM8 (0.63) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL11620503 0.81 TRPM8 (0.61) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL28123392 0.79 TRPM8 (0.60) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL9023222 0.79 NR4A2 (0.66) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL6764594 0.79 MAOB (0.61) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL4906659 0.79 GABRA1 (0.71) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL9022998 0.77 TRPM8 (0.64) TRPM8GABRA1GABRA3GABRG2GABRB3
SCHEMBL9022994 0.77 TRPM8 (0.64) TRPM8GABRA1GABRA3GABRG2GABRB3
SCHEMBL7376780 0.77 ALDH1A1 (0.59) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2
SCHEMBL18549394 0.76 LTA4H (0.63) TRPM8ALDH1A1HPGDMDH2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1425010-B8 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS JANSSEN PHARMACEUTICALS INC (US) 2012-03-28 EP disclosed
EP-1425010-A4 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS ORTHO MCNEIL PHARM INC (US) 2009-07-29 EP disclosed
EP-1425010-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS Ortho-McNeil Pharmaceutical, Inc. (US) 2004-06-09 EP disclosed
WO-2002060438-A1 SUBSTITUTED INDOLES AND THEIR USE AS INTEGRIN ANTAGONISTS 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) 2002-08-08 WO disclosed